ABOUT T1DType Type-1 diabetes research group JDRF has launched a campaign that calls on insurers to provide coverage which gives sufferers better control over the costs incurred by their disease. Called #Coverage2Control, the campaign urges insurers to cover costs for insulin, diabetes management tools and life-saving technology, as well as give patients the option to choose their preferred insulin pump. The campaign, which is being run in partnership with Diabetes UK, aims to raise awareness of Type 1, an autoimmune disease where blood sugar levels are abnormally high or low.
Type-1 diabetes research group JDRF has launched a campaign that calls on insurers to provide coverage which gives sufferers better control over the costs incurred by their disease. Called #Coverage2Control, the campaign urges insurers to cover costs for insulin, diabetes management tools and life-saving technology, as well as give patients the option to choose their preferred insulin pump. The campaign, which is being run in partnership with Diabetes UK, aims to raise awareness of Type 1, an autoimmune disease where blood sugar levels are abnormally high or low.